Aurobindo Pharma Ltd

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 201903 Annual Report Page No: 147)

  • Market Cap: 53,112 Cr.
  • Current Price: 906.45
  • 52 weeks High / Low 923.05 / 281.15
  • Book Value: 286.90
  • Stock P/E: 18.63
  • Dividend Yield: 0.33 %
  • ROCE: 18.45 %
  • ROE: 19.01 %
  • Sales Growth (3Yrs): 12.41 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 1.00
Edit ratios
Pros:
Company has a good return on equity (ROE) track record: 3 Years ROE 22.63%
Cons:
Company might be capitalizing the interest cost

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
3,679 4,436 4,336 4,049 4,250 4,751 5,270 5,292 5,445 5,600 5,895 6,158
2,845 3,319 3,311 3,261 3,539 3,765 4,183 4,235 4,298 4,460 4,688 4,862
Operating Profit 834 1,117 1,026 788 711 986 1,086 1,057 1,146 1,140 1,207 1,297
OPM % 23% 25% 24% 19% 17% 21% 21% 20% 21% 20% 20% 21%
Other Income 23 11 33 44 44 -0 41 -4 8 8 18 45
Interest 17 17 19 25 30 35 48 50 50 41 37 32
Depreciation 131 132 138 157 155 164 163 187 241 243 250 232
Profit before tax 709 979 902 651 571 787 917 816 863 864 938 1,078
Tax % 27% 20% 34% 19% 20% 22% 22% 28% 26% 26% 25% 21%
Net Profit 519 781 595 529 456 611 712 585 636 640 705 850
EPS in Rs 8.85 13.33 10.16 9.02 7.78 10.44 12.15 9.99 10.85 10.92 12.04 14.50
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
2,420 3,023 3,515 4,368 4,615 5,842 8,089 12,103 13,772 14,910 16,463 19,564 23,098
2,084 2,850 2,744 3,405 4,050 4,970 5,952 9,524 10,579 11,469 12,691 15,612 18,308
Operating Profit 336 173 772 963 565 873 2,137 2,579 3,193 3,441 3,772 3,952 4,791
OPM % 14% 6% 22% 22% 12% 15% 26% 21% 23% 23% 23% 20% 21%
Other Income 126 170 205 61 -300 17 18 81 200 115 105 70 79
Interest 69 93 73 65 277 267 310 160 257 67 78 263 160
Depreciation 100 128 149 172 201 249 313 333 392 428 558 668 967
Profit before tax 292 122 754 788 -213 374 1,533 2,168 2,744 3,061 3,241 3,091 3,743
Tax % 18% 18% 25% 29% 42% 22% 24% 28% 26% 25% 25% 24%
Net Profit 238 100 563 563 -124 294 1,173 1,576 2,025 2,302 2,423 2,365 2,831
EPS in Rs 4.38 1.79 10.02 1.90 0.00 4.92 19.87 26.55 34.61 38.89 41.36 40.36 48.31
Dividend Payout % 7% 24% 5% 10% -24% 15% 7% 8% 7% 6% 6% 6%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:20.53%
5 Years:19.32%
3 Years:12.41%
TTM:18.07%
Compounded Profit Growth
10 Years:44.66%
5 Years:15.65%
3 Years:6.21%
TTM:17.28%
Stock Price CAGR
10 Years:25.18%
5 Years:3.55%
3 Years:9.77%
1 Year:51.37%
Return on Equity
10 Years:25.10%
5 Years:25.47%
3 Years:22.63%
Last Year:19.01%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
27 27 28 29 29 29 29 29 59 59 59 59 59
Reserves 1,097 1,214 1,801 2,416 2,311 2,577 3,721 5,127 7,229 9,313 11,622 13,832 16,752
Borrowings 1,908 2,333 2,155 2,414 3,096 3,435 3,769 4,451 5,041 3,364 4,770 6,967 5,687
602 650 804 1,009 798 1,232 1,970 3,303 3,568 3,464 4,492 5,414 6,429
Total Liabilities 3,634 4,224 4,787 5,868 6,234 7,273 9,490 12,910 15,896 16,200 20,942 26,271 28,926
1,237 1,399 1,711 1,739 2,195 2,639 2,722 3,706 4,180 4,834 6,521 8,475 9,761
CWIP 278 536 570 657 645 219 310 420 848 1,458 1,583 1,668 1,622
Investments 60 0 0 39 39 22 20 20 123 246 312 360 555
2,059 2,289 2,506 3,433 3,355 4,393 6,439 8,765 10,745 9,662 12,527 15,768 16,989
Total Assets 3,634 4,224 4,787 5,868 6,234 7,273 9,490 12,910 15,896 16,200 20,942 26,271 28,926

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
195 103 427 335 326 275 646 1,237 1,420 3,279 1,955 1,622
-107 -406 -398 -603 -563 -246 -819 -1,017 -1,446 -1,787 -1,927 -2,875
-217 165 -84 407 119 108 118 93 365 -1,915 864 1,919
Net Cash Flow -129 -139 -55 139 -118 137 -55 313 340 -424 892 666

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 12% 5% 22% 20% 8% 11% 27% 27% 27% 25% 23% 18%
Debtor Days 100 107 99 103 98 100 119 107 122 68 68 64
Inventory Turnover 2.09 2.18 1.94 1.86 1.83 1.91 1.84 1.96 1.72 1.64 1.42 1.41

Shareholding pattern in percentages

Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020
51.87 51.87 51.87 51.87 51.87 51.87 51.87 51.87 51.87 51.87 52.01 52.01
18.80 18.90 17.99 17.77 19.11 20.07 21.47 21.96 21.95 21.42 22.26 22.63
15.35 15.55 15.64 15.83 15.04 14.44 13.69 13.27 13.00 13.18 12.56 12.56
13.98 13.67 14.50 14.53 13.98 13.62 12.97 12.90 13.18 13.53 13.16 12.80

Recent announcements

View all announcements

Annual reports

Credit ratings